Jenburkt Pharmaceuticals Ltd.
| BSE: 524731 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE354A01013 |
| BSE 09:27 | 17 Aug | 567.25 |
10.20 (1.83%) |
OPEN
558.00 |
HIGH
567.25 |
LOW
558.00 |
| NSE 05:30 | 01 Jan | Jenburkt Pharmaceuticals Ltd |
| OPEN | 558.00 |
| PREVIOUS CLOSE | 557.05 |
| VOLUME | 52 |
| 52-Week high | 699.70 |
| 52-Week low | 452.00 |
| P/E | 11.03 |
| Mkt Cap.(Rs cr) | 260 |
| Buy Price | 555.05 |
| Buy Qty | 1.00 |
| Sell Price | 566.50 |
| Sell Qty | 1.00 |
Jenburkt Pharmaceuticals Ltd. (JENBURKTPHARMA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 918.10 | 0.40 | 966.90 | 733.95 | 220279.73 |
| Divi's Lab. | 3754.90 | 0.55 | 5425.00 | 3365.10 | 99673.82 |
| Cipla | 1035.20 | 0.13 | 1083.15 | 850.00 | 83540.64 |
| Dr Reddy's Labs | 4313.00 | 0.37 | 5078.80 | 3655.00 | 71785.57 |
| Apollo Hospitals | 4336.60 | -0.33 | 5930.70 | 3365.90 | 62351.63 |
| Torrent Pharma. | 1563.10 | -0.62 | 1652.23 | 1242.50 | 52901.56 |
| Piramal Enterp. | 1935.00 | 0.38 | 3013.00 | 1561.00 | 46178.77 |
| Zydus Lifesci. | 397.70 | -0.20 | 576.25 | 319.40 | 40712.55 |
| Abbott India | 19096.75 | -0.14 | 23902.30 | 15525.00 | 40580.59 |
| Gland Pharma | 2358.80 | 0.83 | 4299.25 | 2180.10 | 38849.43 |
| Max Healthcare | 394.85 | -0.47 | 472.60 | 312.40 | 38285.84 |
| Biocon | 317.60 | 0.13 | 410.50 | 305.00 | 38131.06 |
| Alkem Lab | 2952.40 | 0.21 | 4067.70 | 2835.00 | 35295.94 |
| Aurobindo Pharma | 584.20 | 0.06 | 769.95 | 503.40 | 34228.28 |
| Laurus Labs | 582.50 | 0.88 | 716.40 | 433.20 | 31300.64 |
| Lupin | 683.35 | -0.11 | 995.00 | 583.05 | 31068.51 |
| Glaxosmi. Pharma | 1449.60 | 0.02 | 1917.00 | 1372.80 | 24557.67 |
| Syngene Intl. | 591.90 | -0.55 | 686.00 | 508.10 | 23760.64 |
| Ipca Labs. | 927.70 | 0.21 | 1383.55 | 831.40 | 23535.75 |
| Fortis Health. | 296.10 | 1.40 | 313.80 | 219.80 | 22354.37 |
Quick Links for Jenburkt Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
